{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:23:30Z","timestamp":1778671410390,"version":"3.51.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Huntington Study Group"},{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Huntington' Disease Network"},{"name":"Cluster of Excellence Neurocure"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173872","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T21:49:18Z","timestamp":1490132958000},"page":"e0173872","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Bupropion for the treatment of apathy in Huntington\u2019s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial"],"prefix":"10.1371","volume":"12","author":[{"given":"Harald","family":"Gelderblom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"W\u00fcstenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisanne","family":"M\u00fctze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurd","family":"S\u00fcssmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schlattmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"issue":"4","key":"ref1","first-page":"219","article-title":"Behavioral changes in Huntington Disease","volume":"14","author":"D Craufurd","year":"2001","journal-title":"Neuropsychiatry, neuropsychology, and behavioral neurology"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits","volume":"16","author":"R Levy","year":"2006","journal-title":"Cerebral cortex"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp.2007.136895","article-title":"The nosological position of apathy in clinical practice","volume":"79","author":"SE Starkstein","year":"2008","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington&apos;s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"SJ Tabrizi","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington&apos;s disease cohort (REGISTRY)","volume":"85","author":"E van Duijn","year":"2014","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"5\u20136","key":"ref6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000091523","article-title":"Cognitive impairment related to apathy in early Huntington&apos;s disease","volume":"21","author":"S Baudic","year":"2006","journal-title":"Dementia and geriatric cognitive disorders"},{"key":"ref7","first-page":"1","article-title":"Dopamine and Huntington&apos;s disease","author":"LC Schwab","year":"2015","journal-title":"Expert review of neurotherapeutics"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington&apos;s disease: A balancing act","volume":"16","author":"VM Andre","year":"2010","journal-title":"CNS neuroscience & therapeutics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnana.2011.00055","article-title":"Huntington&apos;s Disease and Striatal Signaling","volume":"5","author":"E Roze","year":"2011","journal-title":"Frontiers in neuroanatomy"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000339528","article-title":"Consistent neurodegeneration and its association with clinical progression in Huntington&apos;s disease: a coordinate-based meta-analysis","volume":"12","author":"I Dogan","year":"2013","journal-title":"Neuro-degenerative diseases"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington&apos;s disease","volume":"24","author":"JC Thompson","year":"2012","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","article-title":"Distribution of grey matter atrophy in Huntington&apos;s disease patients: a combined ROI-based and voxel-based morphometric study","volume":"32","author":"G Douaud","year":"2006","journal-title":"NeuroImage"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","article-title":"In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease","volume":"63","author":"C Fennema-Notestine","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"ref14","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington&apos;s disease: a voxel based morphometric MRI study","volume":"75","author":"J Kassubek","year":"2004","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"52","key":"ref15","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1523\/JNEUROSCI.2058-08.2008","article-title":"Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release","volume":"28","author":"BH Schott","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/nimg.2000.0593","article-title":"FMRI visualization of brain activity during a monetary incentive delay task","volume":"12","author":"B Knutson","year":"2000","journal-title":"NeuroImage"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.expneurol.2012.02.003","article-title":"Altered ventral striatal activation during reward and punishment processing in premanifest Huntington&apos;s disease: a functional magnetic resonance study","volume":"235","author":"B Enzi","year":"2012","journal-title":"Exp Neurol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11940-011-0140-y","article-title":"Treatment of Apathy in Huntington&apos;s Disease and Other Movement Disorders","volume":"13","author":"A Krishnamoorthy","year":"2011","journal-title":"Current treatment options in neurology"},{"key":"ref19","first-page":"1","article-title":"Advancing pharmacotherapy for treating Huntington&apos;s disease: a review of the existing literature","author":"SL Mason","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/jnp.7.1.23","article-title":"Apathy: a treatable syndrome","volume":"7","author":"RS Marin","year":"1995","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0269881104043284","article-title":"Bupropion in the management of apathy","volume":"18","author":"C Corcoran","year":"2004","journal-title":"J Psychopharmacol"},{"key":"ref22","first-page":"A29","article-title":"Bupropion: first experience in Huntington\u2019s Disease","volume":"79","author":"K AJ Strassburger","year":"2008","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/jnp.17.2.167","article-title":"Apathy is associated with volume of the nucleus accumbens in patients infected with HIV","volume":"17","author":"RH Paul","year":"2005","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1002\/hbm.22540","article-title":"Reward anticipation in the adolescent and aging brain","volume":"35","author":"RC Lorenz","year":"2014","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/jnnp.2004.052795","article-title":"On the overlap between apathy and depression in dementia","volume":"76","author":"SE Starkstein","year":"2005","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/jnp.3.3.243","article-title":"Apathy: a neuropsychiatric syndrome","volume":"3","author":"RS Marin","year":"1991","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the Apathy Evaluation Scale","volume":"38","author":"RS Marin","year":"1991","journal-title":"Psychiatry Res"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington&apos;s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"e49787","DOI":"10.1371\/journal.pone.0049787","article-title":"Age differences in neural activity during slot machine gambling: an fMRI study","volume":"7","author":"AC McCarrey","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.euroneuro.2014.08.018","article-title":"Quantifying motivational deficits and apathy: a review of the literature","volume":"25","author":"M Weiser","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","article-title":"Proposed diagnostic criteria for apathy in Alzheimer&apos;s disease and other neuropsychiatric disorders","volume":"24","author":"P Robert","year":"2009","journal-title":"European psychiatry: the journal of the Association of European Psychiatrists"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JHD-140133","article-title":"Rating Apathy in Huntington&apos;s Disease: Patients and Companions Agree","volume":"4","author":"S Mason","year":"2015","journal-title":"Journal of Huntington's disease"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","article-title":"&quot;Frontal&quot; behaviors before the diagnosis of Huntington&apos;s disease and their relationship to markers of disease progression: evidence of early lack of awareness","volume":"22","author":"K Duff","year":"2010","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"12","key":"ref34","first-page":"714","article-title":"Psychometric properties of a German version of the Apathy Evaluation Scale","volume":"74","author":"U Lueken","year":"2006","journal-title":"Fortschritte der Neurologie-Psychiatrie"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpsychores.2010.01.012","article-title":"Are the available apathy measures reliable and valid? A review of the psychometric evidence","volume":"70","author":"DE Clarke","year":"2011","journal-title":"Journal of psychosomatic research"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-1819.2011.02315.x","article-title":"Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer&apos;s disease","volume":"66","author":"CJ Hsieh","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gps.2508","article-title":"Diagnostic criteria for apathy in clinical practice","volume":"26","author":"E Mulin","year":"2011","journal-title":"International journal of geriatric psychiatry"},{"issue":"13\u201314","key":"ref38","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3109\/02699050903379347","article-title":"Measuring apathy after traumatic brain injury: Psychometric properties of the Apathy Evaluation Scale and the Frontal Systems Behavior Scale","volume":"23","author":"AT Lane-Brown","year":"2009","journal-title":"Brain injury"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0891988715573534","article-title":"Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials","volume":"28","author":"J Cummings","year":"2015","journal-title":"Journal of geriatric psychiatry and neurology"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1176\/jnp.17.3.378","article-title":"A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington&apos;s disease","volume":"17","author":"A Chatterjee","year":"2005","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/mds.26675","article-title":"Rating scales for behavioral symptoms in Huntington&apos;s disease: Critique and recommendations","volume":"31","author":"TA Mestre","year":"2016","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mds.20739","article-title":"Huntington&apos;s disease patients have selective problems with insight","volume":"21","author":"AK Ho","year":"2006","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13803390600718958","article-title":"Patients with Huntington&apos;s disease have impaired awareness of cognitive, emotional, and functional abilities","volume":"29","author":"KF Hoth","year":"2007","journal-title":"Journal of clinical and experimental neuropsychology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cortex.2014.07.019","article-title":"Anosognosia in Alzheimer&apos;s disease: diagnosis, frequency, mechanism and clinical correlates","volume":"61","author":"SE Starkstein","year":"2014","journal-title":"Cortex; a journal devoted to the study of the nervous system and behavior"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1017\/S1041610213000562","article-title":"Caregiver rating bias in mild cognitive impairment and mild Alzheimer&apos;s disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains","volume":"25","author":"L Pfeifer","year":"2013","journal-title":"International psychogeriatrics \/ IPA"},{"key":"ref46","article-title":"Characterization of reward and effort mechanisms in apathy","author":"V Bonnelle","year":"2014","journal-title":"Journal of physiology, Paris"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington&apos;s disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"JG de Yebenes","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.2016.8655","article-title":"Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial","volume":"316","author":"S Frank","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mds.24062","article-title":"Placebo effect characteristics observed in a single, international, longitudinal study in Huntington&apos;s disease","volume":"27","author":"E Cubo","year":"2012","journal-title":"Movement disorders: official journal of the Movement Disorder Society"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T06:00:10Z","timestamp":1601791210000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173872"}},"subtitle":[],"editor":[{"given":"Alfonso","family":"Fasano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173872","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}